Engineered oncolytic virus armed with anti-PCSK9 scFv boosts long-term CD8<sup>+</sup> T cell immunity via rewiring MHC-I antigen presentation. [PDF]
Feng H +13 more
europepmc +1 more source
Impact of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor on Immune-Inflammatory Responses in the Acute Phase of Ischemic Stroke. [PDF]
Li Z +14 more
europepmc +1 more source
PRMT3-Mediated Arginine Methylation Stabilizes PCSK9 to Promote Aortic Valve Calcification. [PDF]
Zhang X +18 more
europepmc +1 more source
Optimized lentivirus-derived virus-like particles for efficient delivery of Cas9-based genome editors. [PDF]
Liu B +5 more
europepmc +1 more source
The Cerebellum's Role in Mental Illness: New Insights From Genetic Studies. [PDF]
Roffman JL.
europepmc +1 more source
New frontiers in the treatment of hypercholesterolaemia: oral inhibition of PCSK9. [PDF]
Arnaboldi L, Tang Z, Ferri N, Corsini A.
europepmc +1 more source
Therapeutic Potential of PCSK9 Inhibitors in Regulating Neuroinflammation in Acute Ischemic Stroke. [PDF]
Pu L +6 more
europepmc +1 more source
Correction: SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion.
Chen XW +16 more
europepmc +1 more source
Familial Hypercholesterolemia in Women: Diagnosis, Treatment, and Cardiovascular Outcomes Across the Lifespan. [PDF]
Karungi I +3 more
europepmc +1 more source
Bioactive peptides targeting dyslipidemia and atherosclerosis: from computational discovery and data bottlenecks to precision medicine translation. [PDF]
Yin W, Wang Q, Zeng Z, Xie X.
europepmc +1 more source

